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Introduction: Enhanced inflammatory-oxi-
dative status is well established in chronic 
kidney disease. Objective: The objective 
of this study was to evaluate the oxida-
tive- inflammatory status and iron indi-
ces in patients undergoing maintenance 
hemodialysis (HD) with serum ferritin 
lower than 500ng/mL, and to correlate 
them with nutritional status. Method: In 
a cross-sectional survey 35 HD patients 
(23 with normal nutritional status, 12 
with Protein-Energy-Wasting syndrome, 
PEW), and healthy volunteers (n = 35) 
were studied. Serum concentration of 
iron, ferritin, transferrin saturation, ma-
londialdehyde (MDA), protein carbonyl 
(PC), high-sensitive serum C - reactive 
protein (hs-CRP) and blood counts were 
determined. The nutritional status was 
determined by anthropometric and bio-
chemical criteria. Results: HD patients 
showed low values of hemoglobin and 
higher values of ferritin, MDA and PC 
when compared with healthy volunteers. 
HD subjects with PEW had higher values 
of PC and hs-PCR as compared to HD 
patients with normal nutritional status. 
A multiple logistic regression analysis 
showed that the independent variables 
PC (Wald Statistic 4.25, p = 0.039) and 
hs-CRP (Wald Statistic 4.83, p = 0.028) 
where related with the patients' nutritio-
nal condition. Conclusion: In HD patients 
with serum ferritin below 500 ng/mL was 
observed one association of the markers 
of oxidative stress and inflammation with 
poor nutritional status independently of 
serum ferritin, gender and age.
Introdução: Na doença renal crônica, a 
presença de um estado inflamatório-oxi-
dativo aumentado está bem estabelecida. 
Objetivo: O objetivo do presente estudo foi 
avaliar o estado oxidativo e inflamatório 
e o perfil do ferro em pacientes submeti-
dos à hemodiálise crônica de manutenção, 
com ferritina menor do que 500 ng/mL, e 
correlacioná-los com o estado nutricional. 
Método: Em estudo transversal, em 35 paci-
entes sob hemodiálise (23 com estado nutri-
cional normal, 12 com desnutrição energé-
tico-proteica (DEP) e 35 voluntários sadios 
foram determinados os índices hematimé-
tricos e as concentrações séricas do ferro, da 
ferritina e avaliada a saturação de transferri-
na. O estado oxidativo foi determinado por 
meio das concentrações séricas do malondi-
aldeído (MDA) e da proteína carbonil (PC). 
Nos indivíduos sob hemodiálise o estado 
inflamatório foi avaliado por meio da pro-
teína C reativa ultrassensível determinada 
no soro (hs-PCR). O estado nutricional foi 
determinado por critérios antropométricos 
e bioquímicos. Resultados: Os pacientes da 
hemodiálise mostraram anemia e um estado 
oxidativo mais elevado do que os voluntári-
os sadios. Os pacientes hemodialisados com 
DPE mostraram ferritina e um estado in-
flamatório-oxidativo mais elevado se com-
parados aos com boa condição nutricional. 
Em análise de regressão logística múltipla, 
os níveis séricos de PC e hs-CRP foram cor-
relacionados com o estado nutricional. PC 
(Estatística Wald 4.25, p = 0,039), CRP (Es-
tatística Wald 4.83, p = 0,028). Conclusão: 
Em indivíduos submetidos à hemodiálise, 
com ferritina menor do que 500 ng/mL. Ob-
servou-se uma associação entre os marcado-
res de estresse oxidativo e inflamatório com 
o estado nutricional, independentemente da 
idade, gênero e dos índices do ferro.
Associação dos marcadores do estado oxidativo e inflamatório 
com a desnutrição em pacientes hemodialisados com ferritina 
menor do que 500 ng/mL
The association of markers of oxidative-inflammatory status with 
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IntroductIon
Anemia is a very common condition in advanced 
renal disease and contributes to a higher morbi-
mortality in this group of patients.1,2 Intravenous 
iron is widely used to maintain adequate iron stores 
and prevent iron deficiency anemia. The long-term 
safety of intravenous iron has raised concerns wi-
th respect to oxidative stress, cellular injury, and 
accelerated atherosclerosis.3 Previous data suggest 
that iv iron could increase oxidative stress and 
induce endothelial-cell injury in chronic kidney 
disease patients.4-6
Moreover, uremic patients have an increased 
formation of reactive oxygen species. In addition 
to iron administration, other factors such as uremic 
toxins and hemodialysis, due to aspects related to 
membrane and dialysis-water biocompatibility and 
a chronic inflammatory state, contribute to inten-
sify this oxidative stress leading to greater cardio-
vascular risk.7,8 Furthermore, patients undergoing 
maintenance hemodialysis have a high prevalen-
ce of protein-energy wasting, inflammation, and 
enhanced oxidative stress, the so-called “malnutri-
tion-inflammation complex syndrome”.9,10
It was previously shown that inflammation 
was the possible cause of increased serum ferri-
tin level in 34% of hemodialysis patients.11 Serum 
ferritin values in the range of 200-2000 ng/mL 
may be increased due to non-iron-related factors, 
and PEWhemodialysis patients with ferritin gre-
ater than 800 ng/mL have higher serum hs-CRP 
than those with a serum ferritin value inferior to 
800 ng/mL.12
Currently, there is insufficient evidence to re-
commended IV iron if ferritin > 500 ng/mL, althou-
gh the upper limit of serum ferritin of 800 ng/mL 
may be considered for some patients with poor res-
ponsiveness to erythropoietin.13
Common tests such as serum ferritin and trans-
ferrin saturation lack precision to be a good marker 
of iron status in hemodialysis patients,14,15 and the 
ferritin level threshold below which iron depletion 
can be considered is probably higher than that ob-
served in healthy individuals. The objective of this 
study was to evaluate the oxidative- inflamma-
tory status and iron indices in patients undergoing 
maintenance hemodialysis (HD) with serum ferritin 
lower than 500 ng/mL, and to correlate them with 
nutritional status.
mAterIAls And methods
Fifty-four patients with chronic renal disease submit-
ted to chronic hemodialysis were recruited from one 
outpatient center of dialysis at the University Hospital 
of Brasília. Eligibility criteria included the following: 
18 years old or older, male or female, six or more 
months on dialysis treatment, absence of malignancy, 
acute inflammatory diseases, vasculitis, and haemo-
globinopathies. Also, eligible subjects needed to have 
good adherence and stability to dialysis treatment, 
vascular access to hemodialysis by means of artery-
-venous shunt and ferritin levels lower than 500 ng/
mL. Thirty-five patients met the criteria (19 female 
and 16 male). The causes of chronic kidney disease 
were hypertensive nephrosclerosis (13), chronic glo-
merulonephritis (10), polycystic disease (4), diabetic 
nephropathy (6), and undetermined (2). Eligible HD 
patients represent an ethnically heterogeneous group 
of Brazilian individuals. A written consent was obtai-
ned from the participants according to a protocol ap-
proved by the Faculty of Health Sciences, University 
of Brasilia Ethics Committee. Each patient had been 
undergoing standard bicarbonate HD session three 
times a week, 4 hours per session, using polysulfone 
membrane with blood flow of 300-350 ml/min and 
dialysis flow of 500 ml/min. Prescribed medications 
included angiotensin-converting enzyme inhibitors, 
calcium channel blockers, angiotensin II receptors 
blockers, phosphate binders and vitamin D analo-
gues. None of the patients received hydroxymethyl-
glutaryl-coenzyme A reductase inhibitors (statins), 
antioxidants agents (vitamin C or E) or anti-inflam-
matory drugs. HD subjects were receiving regular 
doses of parenteral iron (IV) to maintain their body 
iron stores and erythropoietin (rHuEPO) to stimula-
te erythropoiesis, according to guidelines for the tre-
atment of anemia in hemodialysis subjects.16,17 Data 
for the total dose of iron supplement and erythro-
poietin administered were obtained from the medical 
records of each patient.
A detailed history of all the patients was taken and 
they underwent clinical examination. Anthropometric 
data includes dry weight (weight after dialysis session), 
body mass index, and assessment of subcutaneous fat 
and muscle mass stores, which were determined using 
a body fat caliper (Cescorf-Brazil). All measurements 
were taken by the same observer on the opposite side 
of the artery-venous shunt. Percentiles of triceps skin-
fold thickness (TSF), mid-arm- circumference (MAC), 
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and mid-arm-muscle circumference (MAMC) were 
calculated according to Frisancho.18 The following 
formula was employed to calculate MAMC: MAMC 
(cm) = MAC (cm) - (TSF (mm) x 0.314).19
The patients’ dietary intake of energy, protein, 
carbohydrate, lipids, and iron was calculated based 
on the averages of three 24-hour dietary intake re-
calls, comprising one day of the weekend and two 
non- consecutive week days. Nutrients, calories and 
protein intake were calculated using data of food 
composition.20 The values obtained were compared 
with those specifically recommended for dialysis 
subjects according to NKF/DOQI.21
Blood samples were drawn immediately before the 
hemodialysis session to determine hemoglobin(Hb), 
hematocrit(Hct), iron, ferritin, and transferrin satura-
tion. After the dialysis session, more blood was taken 
to determine post-dialysis urea to calculate eKtv of 
urea. Mean values of the three measurements were 
used given the high intraindividual variability for fer-
ritin. Albumin, intact paratohormony (iPTH), highly 
sensitive C reactive protein (hsCRP), protein carbonyl 
(PC), and malondialdehyde (MDA) were determi-
ned in the last month of the study. The nutritional 
condition of HD patients was classified according 
to Blackburn.22 To compare oxidative stress (OS) in 
hemodialysis patients and healthy subjects, 35 heal-
thy volunteers pared to age, gender and social status 
were included. They were volunteers of the pilot pro-
ject “Prevalence of risk factors to non-communicable 
chronic diseases on the Federal District -Brasilia, 
Brazil”, which was a cooperative study developed by 
the University of Brasília and the Health Secretary 
of the Federal District. Participants of this study re-
presented a random sample of the population of the 
city of São Sebastião, DF. They were submitted to an 
interview and samples of blood for Hb, iron status 
andOS determinations were drawn the morning after 
the interview, as described in Yokota.23
lAborAtory AnAlysis
A complete blood count including Hb, mean corpus-
cular hemoglobin concentration (MCHC), and Hct 
was done using an automatized cell count (Abbott 
Cell-Dyn 3700SL, Abbott Laboratories, Diagnostic 
Division, Illinois, USA); serum iron, iron binding 
capacity, albumin and urea were measured using an 
autoanalyser (Mega, Bayer, Germany); serum ferritin 
was measured by Enzyme Linked Immuno Sorbent 
Assay (Katal biotechnology- Brazil); iPTH was me-
asured employing chemiluminescent method; hsCRP 
was measured by nephelometric method (Cardiophase 
hsCRP, Dade Behring, Germany). Transferrin satura-
tion percentage was calculated by means of the for-
mula TSAT (%) = Iron/IBC x 100.
Adequacy of dialysis (ekT/v for urea) was calcu-
lated according to the single-compartment model of 
Daurgidas.24
Serum malondialdehyde (MDA) was measured 
by a fluorimetric method based on the reaction be-
tween MDA and thiobarbituric acid (TBA). 50 μL of 
serum, 1 mL of deionized water and 1 mL of TBA 
29 mmol/L in acetic acid were added to each tube, 
agitated and heated in a water bath at 100ºC for 1 
hour. After cooling, 25 μL of HCl 5 mol/L and 3.5 
mL of n-butanol were added, and the tubes were agi-
tated for 5 seconds. The alcoholic phase was sepa-
rated by centrifugation at 900 x g for 10 minutes. 
The sample fluorescence was determined at 547 nm 
with excitation at 525 nm, in spectrofluorometer 
(FP-777 JAS.CO). The standard curve was prepared 
using 1,1,3,3-tretraethoxypropane standard solu-
tions (Sigma, Germany) in the concentration range of 
0 - 0.150 μmol/L, linearity of 0.9816.25
The concentration of serum protein carbonyls 
groups was determined by the spectrophotometric 
method based on the reaction of 2.4-dinitrophenyl-
hydrazine with protein carbonyls. Serum samples 
containing 500 μg of protein were homogenized in 
25 mmols/L Tris, pH 9.0, 6 mols/L urea to a final 
volume of 200 μL. Next, an equal volume of 20% 
trichloroacetic acid was added and centrifuged at 
9,000 x g for 1 minute to precipitate proteins. The 
pellet was re-suspended in 200 μL 25 mmol/L Tris, 
pH 9.0, 6 mols/L urea. 700 μL 0.2% 2.4-dinitro-
phenylhydrazine (2,4-DNPH) in 2 mols/L HCl were 
added to the sample and 700 μL 2 mols/L HCl to a 
blank tube, respectively. Samples were agitated at 4ºC 
for 15 minutes on a shaker (TE-420, Tecnal) at maxi-
mum speed. 700 μL 20% trichloroacetic acid (TCA) 
were added to precipitate the proteins. The pellet was 
washed three times at room temperature with 1 mL 
ethyl acetate:ethanol, 1:1, air dried and re-suspended 
in 500 μL 500 mols/L potassium phosphate, pH 2.5, 
containing 6 mols/L guanidine HCl. The mixture was 
agitated at 4ºC for 30 minutes on a shaker. The ab-
sorbance was measured at 376 nm.26
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stAtisticAl AnAlysis
All Continuous variables were analyzed for normal 
distribution using the Kolmogorov-Smirnov test. 
According the distribution of data the t test or Mann 
Whitney U tests were employed to compare conti-
nuous variables. The Chi-square test and the Fisher 
Exact Test were employed for categorical variables. 
Spearmen correlation test was employed to verify the 
association among ferritin levels and CRP, Tbars and 
PC. Multiple logistic regression analysis was used to 
evaluate which clinical and laboratory independent 
variables where associated with nutritional status. 
The nutritional condition was the dependent outco-
me and age, gender, time on dialysis, ferritin, albu-
min, Tbars, PC, CRP, and Ktv, were included as either 
continuous or dichotomous data. SigmaStat® 3.11/
SigmaPlot 9.01 for windows (Systat Software, Inc, 
USA, 2004) and Prism 4 for Windows® (Graphpad 
Software, Inc., USA, 2005) software packages were 
employed for analysis and graphic design of the data.
A p value of less than 0.05 was considered 
significant.
results
In this study, and according to the NKF-K/DOQI,22 
the dietary intake was suitable for all nutrients except 
forcalories and proteins in 57% of HD patients.
Using the anthropometric and biochemical crite-
ria the hemodialysis patients showed a prevalence of 
34.3% of mild to moderate PEW syndrome accor-
ding to the criteria of Blackburn22 as demonstrated 
in Table 1.
erythropoietin(HrEPo) throughout the study, and the 
doses of both drugs were not statistically different be-
tween those patients with good nutritional condition 
and those with PEW:Iron (mg/Kg/week, 1.73(2.2-1.6) 
vs. 2.1(2.4-1.7); HrEPo(ui/Kg/week): 138.8(199.2-
69.9) vs. 94.3(174.0-86.9) p > 0.05 Mann-Whitney.
PC, Tbars, and hs-CRP levels in HD subjects we-
re not correlate with the ferritin levels. (p > 0.05, 
Spearman Correlation Test).
The different characteristics of HD subjects and 
of those with normal and poor nutritional status are 
shown in Table 3. Gender and diabetic ratios, months 
on dialysis, e kT/v, iron, transferrin saturation, fer-
ritin, albumin, iPTH, Hb, and MDA were not diffe-
rent for the subjects with PEW and those with normal 
nutrition. However, PEW patients showed higher le-
vels of PC and hs-CRP in relation to those with nor-
mal nutritional status. A multiple logistic regression 
analysis showed that the independent variables PC, 
Odds ratio (95% IC) = 5.2 (24.0-1.1), p = 0.039 and 
CRP Odds ratio (95% IC) = 62.1 x 103 (192467.7 
x 103 - 20.0), p = 0.028) where related with the pa-
tients’ nutritional condition independently of age, 
gender, and iron status. Figures 1 and 2 shows res-
pectively that the medians (range) of PC and hs-CRP 
were statistically higher in HD patients with PEW as 
compared with those with good nutritional condition.
dIscussIon
The relationship among haematimetrics and iron in-
dices, OS, and nutritional status in 35 HD patients 
was analyzed in this study. Hb, serum ferritin and OS, 
evaluated by the serum concentration of MDA and 
PC, were also evaluated in 35 healthy volunteers.
Anemia was present in all renal subjects (Hb con-
centration < 14 and < 12 mg/dL for men and women, 
respectively), despite levels of serum ferritin between 
100 to 500 ng/mL, and the use of parenteral iron and 
erythropoietin. Dialysis patients also exhibited higher 
levels of serum MDA and PC in relation to healthy 
volunteers, a factcompatible with the higher oxidati-
ve stress previously observed in renal patients.8,27,28 A 
chronic Inflammatory status described in hemodialy-
sis patients29-31 may contribute to iron functional defi-
ciency by making it difficult to attain the target hema-
tocrit, increasing these individuals’ risk of infections 
and cardiovascular diseases. In addition, an associa-
tion among biomarkers of inflammation, oxidative 
stress, and PEWin HD patients, called the “oxidative 
Comparisons of the levels of Hb, ferritin, and 
the serum markers of oxidative stress between the 
35 healthy volunteers and HD subjects are shown in 
Table 2. Results show that renal subjects have higher 
levels of ferritin, MDA and PC, and lower levels of Hb 
in relation to healthy individuals. Hemodialysis sub-
jects received maintenance doses of iron and human 
Body mass
Triceps skinfold thickness (≤ percentile 5 of the 
standard reference, according to Blackburn22)
Muscle mass
Reduced mid-arm-muscle circumference (MAMC) 
(≤ percentile 5 of the standard reference, according to 
Blackburn22)
tAble 1 Used criteriA for the clinicAl diAgnosis 
 of pew in hemodiAlysis pAtients
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stress complex syndrome”, may play a major role 
in long-term complications affecting morbidity and 
mortality in HD patients.9,32
Serum ferritin is an indicator of iron storage but 
its concentration may be affected by inflammation. 
The influence of the inflammatory status on serum 
ferritin was well demonstrated, mainly in HD patients 
with higher ferritin levels, that is, above 500 ng/mL. 
Our results showed that in HD patients with serum 
ferritin below 500 ng/mL, PC, Tbars, and hs-CRP 
were not correlate with the ferritin levels (p > 0.05, 
Spearman Correlation Test).
In this study, mild to moderate PEW and inade-
quate calorie and protein intake were observed in 
34.3% of the dialysis patients. This group of HD pa-
tients exhibited, in relation to dialysis patients with 
good nutritional status, higher levels of hsCRP and 
higher PC levels compatible with the presence of pro-
tein energy malnutrition, inflammation, and enhan-
ced oxidative stress. Inflammation and oxidative 
stress may act synergistically and tend to be involved 
in the development of long-term complications, inclu-
ding PEW, atherosclerotic cardiovascular and bone 
vascular diseases.9 HD patients also showed higher 









Age (y) 41.0 (47.0-41.0) 36.0 (48.5-30.7) 45.5 (46.5-38.0) .38*
Male:female 16:19 10:13 6:6 .99#
Diabetic:nondiabetic 6:29 4:19 2:10 1.00##
Months on dialysis 26.0 (35.0-13.0) 26.0 (39.5-12.2) 27.0 (34.2-15.2) .50*
Weight (kg) 57.9 (60.8-49.0) 59.1 (61.7-56.7) 53.0 (57.3-44.1) .013**
BMI (kg/m2) 21.4 (23.8-19.8) 23.4 (24.5-21.1) 19.8 (20.7-18.6) < .001*
ekT/v for urea 1.4 (1.5-1.2) 1.4 (1.7-1.2) 1.4 (1.4-1.3) .67*
TSF (mm) 12.8 (18.0-8.7) 15.0 (19.0-11.0) 9.1 (12.4-8.5) .025*
MAMC (cm) 23.2 (25.2-21.3) 23.7 (26.4-22.5) 21.5 (23.1-19.8) .006**
MAC (cm) 27.0 (30.0-24.8) 29.5 (30.8-27.0) 24.5 (26.5-23.5) < .001*
Ferritin (ng/mL) 195.9 (268.4-148.0) 190.3 (259.4-148.0) 201.7 (292.9-154.5) .701**
Iron (mg/mL) 65.3 (89.6-55.7) 70.6 (90.1-55.0) 64.6 (81.0-57.8) .35**
TS (%) 37.8 (48.5-29.2) 38.7 (48.5-32.4) 31.3.7 (45.2-27.7) .25*
Albumin (g/dL) 4.4 (4.6-4.2) 4.4 (4.7-4.3) 4.2 (4.5-4.0) .19*
iPTH (pg/mL) 170.0 (446.0-84.8) 180.0 (499.7-88.1) 140.0 (327-72) .54*
Hb (g/dL) 10.5 (11.4-10.2) 10.6 (11.4-10.2) 10.4 (11.1-9.7) .26**
MDA (µmol/L) 2.1 (3.2-1.6) 2.1 (3.1-1.6) 2.2 (3.2-1.8) .39**
PC (nmol/mg protein) 1.9 (2.6-1.3) 1.7 (2.0-1.1) 2.3 (3.3-1.3) .04**
CRP (mg/dL) 0.3 (0.6-0.3) 0.3 (0.5-0.2) 0.7 (0.9-0.4) .003*
Abbreviations: N: number of subjects; BMI: Body mass index; eKtv for urea, adequacy of dialysis; TSF: Triceps skinfold thickness; MAMC: 
Mid-arm-muscle circumference; MAC: Mid-arm circumference; TS: transferrin saturation; iPTH: Parathyroid hormone; Hb: hemoglobin; 
MDA: malonaldehyde; PC: Protein Carbonyl; CRP: C-reactive protein. Data are expressed as median (interquartile range).* Mann-Whitney 
Test; ** t test; # Fisher Exact Test; ## Chi-square test.
tAble 2 levels of hemoglobin (hb), ferritin, lipid peroxidAtion (mdA) And protein cArbonyl (pc) in heAlth
 volUnteers And in hemodiAlysis pAtients
Variables
Health volunteers Renal patients
p value
N = 35 N = 35
Hb (g/dL) 14.0 (14.9-13.0) 10.5 (11.4-10.2) < 0.001*
Ferritin (ng/mL) 35.1 (122.8-21.8) 195.9 (268.4-148.0) < 0.001#
MDA (µmol/L) 0.2 (0.2-0.1) 2.1 (3.2-1.6) < 0.001*
PC (nmol/mg total protein) 0.9 (1.5-0.7) 1.9 (2.6-1.3) 0.001*
Abbreviations: N: number of subjects; Hb: hemoglobin; MDA: malonaldehyde; PC: Protein Carbonyl. Data are expressed as median 
(interquartile range). * t test; # Mann-Whitney Rank Sum Test.
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ferritin levels and the association between oxidative 
stress and iron status was investigated as well. Iron 
supplements could potentially result in the release of 
free iron and induce production of free radicals by 
means of Fenton reaction.33
Previous evidence has shown that in renal patients 
on hemodialysis treatment enhanced oxidative- in-
flammatory stress may be associated with iron load 
and this may contribute to iron functional deficiency 
by making it difficult to attain the target hemato-
crit.4-6,34-38 However, the lowest level of ferritin to 
maintain control of anemia without inducing oxidati-
ve tissue damage and increasing the risk of infections 
and cardiovascular diseases is still unknown.38
Senol et al.39 found that 34 well-nourished HD pa-
tients had higher hsCRP and lipid peroxidation pro-
ducts (red blood cell malondialdehyde) when compa-
red with 22 healthy controls. They did not observe 
a significant relationship between ferritin and RBC-
MDA when they compared HD patients with normal 
(< 800 ng/ml) and high (> 800 ng/ml) ferritin levels. 
The authors concluded that HD patients have higher 
oxidative and inflammation status, but they could not 
find a relationship between ferritin level and OS ma-
rkers in HD patients receiving erythropoietin.
In the present study, HD patients had lower fer-
ritin cut-off values and approximately 34% showed 
mild calorie-protein wasting. Also, we could not find 
a relationship between ferritin levels and markers of 
oxidative stress and inflammation. Moreover, the mal-
nourished HD patients showed higher values of PC 
and hsCRP as compared with HD patients with good 
nutritional condition. This data confirm the associa-
tion between PEW and higher inflammatory-oxidati-
ve status, independent of iron status. Furthermore, a 
logistic regression analysis showed that the indepen-
dent variables PC and hsCRP were related with the 
nutritional condition independently of age, gender, 
and iron status.
The limitations of this study are its relatively small 
sample size and its cross-sectional nature. The distinc-
tive lipid and protein oxidation pathways or products 
stability may be responsible for the differences in the 
oxidative status observed in our patients.
In conclusion, in this ethnically heterogeneous 
group of Brazilian HD patients, the subjects with 
PEW showed higher oxidative and inflammatory sta-
tus as compared with subjects with normal nutritio-
nal condition.
Furthermore, in HD patients with serum ferritin 
below 500 ng/mL, one association of carbonyl stress-
es and inflammation with poor nutritional condi-
tion was showed to be independent of ferritin levels. 
However, prospective and long-term follow-up stud-
ies are needed to confirm this data.
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